Other changes that deserve attention include jaundice, persistent nausea, unusual tiredness, unexplained bruising, and swelling in the legs. These symptoms can be associated with impaired liver function, but they are not specific to cancer. Their significance depends on the combination of symptoms, medical history, examination, and test results.
One common mistake is to wait until several warning signs appear together. Some people delay seeking care because they assume a symptom must be severe before it matters. Others dismiss changes because they feel well in most other respects. Neither approach is ideal. Persistent symptoms that cannot be explained deserve attention even when they are mild.
At the same time, it is important not to interpret every minor change as a sign of cancer. Temporary appetite loss during an illness or a brief period of abdominal discomfort may have a straightforward explanation. The concern increases when symptoms persist, worsen, recur without explanation, or appear alongside other significant changes.
A healthcare professional can help determine whether testing is needed. Depending on the situation, this may include a physical examination, blood tests to assess liver function, and imaging such as ultrasound, CT, or MRI. These investigations help evaluate possible causes; they do not all need to be performed on every person with abdominal symptoms.
People with known liver disease or chronic hepatitis should follow the monitoring plan recommended by their healthcare team. Some people at higher risk of hepatocellular carcinoma may be advised to undergo regular surveillance, often involving liver ultrasound with or without a blood test called alpha-fetoprotein, depending on local guidelines and individual circumstances.
Routine surveillance is different from investigating a new symptom. A person should not wait for their next scheduled screening appointment if they develop concerning changes that require earlier assessment.
The practical message is to pay attention to sustained changes in weight, appetite, abdominal comfort, and abdominal size. These symptoms have many possible causes, but identifying the cause is more useful than guessing. When a symptom persists or is accompanied by jaundice or other concerning signs, seek medical advice rather than relying on online warning lists.
Chapter 4: How Doctors Check for Liver Cancer
Recognizing possible symptoms is only the beginning. Diagnosing liver cancer requires a structured medical assessment because many conditions can cause similar changes. A person with itching, fatigue, abdominal discomfort, or altered appetite may need testing, but those symptoms alone cannot establish whether cancer is present.
The process usually begins with a discussion of medical history and current symptoms. A clinician may ask when the changes began, whether they are getting worse, and whether there are other symptoms such as jaundice, abdominal swelling, fever, or unintended weight loss. They may also ask about hepatitis infections, alcohol use, metabolic conditions, previous liver problems, and medicines that could affect liver function.
The physical examination may include checking the abdomen for tenderness, enlargement of the liver, or fluid accumulation. The clinician may also look for jaundice, swelling in the legs, or other signs of chronic liver disease. These findings can help guide the next steps, but an examination alone usually cannot confirm or exclude liver cancer.
Blood tests are often part of the investigation. Liver blood tests can measure enzymes and substances that provide information about liver injury and function. Bilirubin levels may help explain jaundice, while tests of blood clotting and other measures can provide additional information about how well the liver is functioning.
A blood test cannot, by itself, reliably diagnose liver cancer. Some people with liver cancer may have relatively unremarkable liver blood test results, while people without cancer may have abnormal results because of hepatitis, medication effects, fatty liver disease, or other conditions.
Doctors may also measure alpha-fetoprotein, often abbreviated as AFP, in certain circumstances. AFP can be elevated in some people with hepatocellular carcinoma, but it is not a perfect test. Some people with liver cancer have normal AFP levels, and elevated levels can occur in conditions other than cancer. Its meaning depends on the clinical situation and other findings.
Imaging is particularly important. Ultrasound can help identify abnormalities in the liver and is commonly used in surveillance for people at increased risk of hepatocellular carcinoma. If an abnormal area is detected, further imaging may be needed to understand its characteristics.
A CT scan or MRI can provide more detailed information about the size, location, blood supply, and appearance of a suspicious liver lesion. Certain imaging patterns are highly informative in people with the appropriate risk factors. In some cases, clinicians can establish a diagnosis from characteristic imaging findings without taking a tissue sample.
In other situations, a biopsy may be needed. This involves collecting a small sample of tissue for examination under a microscope. Whether a biopsy is appropriate depends on the appearance of the lesion, the patient's medical history, and the information already available from imaging and blood tests. Not every suspected liver tumor requires a biopsy.
If cancer is confirmed, further evaluation helps determine its extent and whether it has spread. Doctors may assess the number and size of tumors, the involvement of blood vessels, the condition of the remaining liver tissue, and the person's general health. These details are essential because treatment choices depend not only on the tumor but also on how well the liver is functioning.
Treatment may include surgery to remove a tumor, liver transplantation in selected cases, local treatments that target a tumor, radiation in certain circumstances, or medicines such as targeted therapy and immunotherapy. The most appropriate approach depends on the type and stage of cancer, liver function, overall health, and individual preferences.
Early detection can expand the range of treatment options for some patients, but it is important not to promise a particular outcome. Liver cancer varies considerably between individuals, and the outlook depends on several factors. A healthcare team can explain the likely benefits, risks, and goals of the available treatments.
For people who have chronic hepatitis or cirrhosis, regular surveillance may be recommended because their risk of liver cancer is higher. Surveillance is intended to detect cancer before symptoms develop. The recommended schedule and method depend on the person's risk profile and local clinical guidance.